Health
UK Biobank suspends access following Alibaba revelations
Following recent revelations in The Guardian on breaches of UK Biobank data, the charity has suspended access to set in place a strict limit on the size of files that can be taken off the platform.
“We found that de-identified participant data made available to researchers at three academic institutions were listed for sale on a consumer website in China, owned by Alibaba," said CEO and Principal Investigator of UK Biobank, Professor Sir Rory Collins. "With support from both the UK and Chinese governments, Alibaba swiftly removed those listings before any sales were made. This is a clear breach of the contract signed by these academic institutions and they, along with the individuals involved, have had their access suspended.”
As a result of the data breach the UK Biobank has temporarily suspended all access, while they put in place a strict limit on the size of files that can be taken off the platform. In addition, the charity says that...

Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
-
FIFA4 days agoFIFA faces mounting challenges ahead of 2026 World Cup ticket rush
-
Aviation/airlines3 days agoCommission and Eurocontrol launch platform to improve monitoring of the non-CO₂ climate impacts of aviation
-
Business4 days agoThe EU-Mercosur trade agreement
-
European Commission3 days agoEuropean Commission increases its funding target for the first half of 2026
